Albuterol drug data and news

---

Barrier Therapeutics to Present Data on Vusion(TM) and Sebazole(TM ...  Mar 3, 2006
Ointment for the treatment of diaper dermatitis complicated by candidiasis, the Company currently markets Solagé® (mequinol 2%, tretinoin 0.01%) Topical ... - Market Wire (press release)

TODAY ON PHARMALIVE.COM  Mar 3, 2006
Extina(R) (ketoconazole) VersaFoam-HF, 2%, to treat seborrheic dermatitis; and Velac(R) (a combination of 1% clindamycin and 0.025% tretinoin) Gel, for ... - PharmaLive.com (press release),

Acne and Wrinkles: Double Trouble?  Mar 1, 2006
...that a report published in Journal of the American Academy of Dermatology recommends raising the age for insurance coverage of the acne drug tretinoin to at ... - Fashion Monitor Toronto,

Barrier Therapeutics Announces Fourth Quarter and Year End 2005 ...  Feb 27, 2006
...dermatitis complicated by candidiasis which was recently approved by the FDA, the Company currently markets Solagé® (mequinol 2%, tretinoin 0.01%) Topical ... - Market Wire (press release)

Juvenile and adult acne  Feb 23, 2006
Adapalene, tazarotene and tretinoin are topical pharmaceuticals approved in 2005 by the US Food and Drug Administration (FDA) and have been found to have ... - Village News Network,

Connetics Names Freddie Park Vice President, Intellectual Property ...  Feb 6, 2006
...acitretin) capsules and Evoclin(TM) (clindamycin) Foam, 1%. Connetics is developing Velac(R) (a combination of 1% clindamycin and 0.025% tretinoin) Gel, for ... - Genetic Engineering News,

Traditional Medicine For Acne And Its Side Effects  Feb 10, 2006
Retin-A (tretinoin) is a combination of retinoic acid and vitamin A acid. It was designed to treat acne, sun damage, and wrinkles. ... - DailyIndia.com,

Options for Adult Acne  Feb 7, 2006
If your acne doesn’t respond, you may want to see your care provider for a stronger prescription acne lotion such a tretinoin (Retin-A, Renova) or adapaline ... - Fashion Monitor Toronto,

Seven steps to turn back time  Feb 13, 2006
..."Also, retinol- and tretinoin-based products can be added because of their benefits of light exfoliation and unclogging pores, pumping collagen, balancing out ... - myDNA.com,

Use Of A Microsponge in Drug Delivery Systems  Feb 6, 2006
2004. Nyirady J, Bennett ML, Advancement of tretinoin through the microsphere technology, Cosmet. Dermatol; 2001, 14: 22–24. S ... - Pharmaceutical Processing,

Barrier Therapeutics to Present at Roth Capital Partners ...  Feb 14, 2006
The Company currently markets Solage® (mequinol 2%, tretinoin 0.01%) Topical Solution in the US and Canada for the treatment of solar lentigines, a common ... - Market Wire (press release)

FDA Approves Vusion Ointment for the Treatment of Diaper ...  Feb 17, 2006
...(mequinol 2%, tretinoin 0.01%) Topical Solution in the US and Canada for the treatment of solar lentigines, a common condition also known as "age spots," and ... - PharmaLive.com (press release),

Obagi Skin Care Products are the #1 Skin Care Line Recommended by ...  Feb 16, 2006
The Obagi Nu-Derm System uses a unique combination of active and prescription ingredients (including Tretinoin and Hydroquinone 4%) to maximize penetration to ... - PR Web (press release),

Help fighting a double-whammy  Jan 27, 2006
Another option to address wrinkles and blemishes is the active ingredient tretinoin, found in prescription products such as Renova, Tazorac and Retin-A ... - Dallas Morning News (subscription),

Connetics Names Freddie Park Vice President, Intellectual Property ...  Feb 6, 2006
...acitretin) capsules and Evoclin(TM) (clindamycin) Foam, 1%. Connetics is developing Velac(R) (a combination of 1% clindamycin and 0.025% tretinoin) Gel, for ... - Genetic Engineering News,

Options for Adult Acne  Feb 7, 2006
If your acne doesn’t respond, you may want to see your care provider for a stronger prescription acne lotion such a tretinoin (Retin-A, Renova) or adapaline ... - Fashion Monitor Toronto,

Use Of A Microsponge in Drug Delivery Systems  Feb 6, 2006
2004. Nyirady J, Bennett ML, Advancement of tretinoin through the microsphere technology, Cosmet. Dermatol; 2001, 14: 22–24. S ... - Pharmaceutical Processing,

Makeover 911 : Dealing with post-New Year breakouts  Jan 12, 2006
...antibacterial monolaurin gel; VMV Superskin 3 Acne controlling exfoliating astringent; Belo CHAT 2% (Clindamycin, Hydroquinone, Alum and Tretinoin); or Mario ... - INQ7.net,

Connetics Acquires PediaMed Sales Organization; Enters Pediatric ...  Jan 10, 2006
...its license agreement with Astellas Pharma Europe BV (formerly Yamanouchi Europe BV) for Velac(R) (a combination of 1% clindamycin and 0.025% tretinoin) Gel to ... - Genetic Engineering News,

Doctors fear acne drug rules go too far  Jan 30, 2006
And chemical peels and retinoids like adapalene (brand name Differin) and tretinoin (Retin-A) help too, by preventing dead skin cells from clogging pores. ... - Atlanta Journal Constitution (subscription),

AP Pharma Completes Financing for up to $30 Million; Sells Royalty ...  Jan 18, 2006
Retin-A Micro 0.04% and Retin-A Micro 0.1% are leading prescription topical acne treatments formulated with the active ingredient tretinoin incorporated in AP ... - Genetic Engineering News,

Twitching eye likely signals eyestrain, not diet problem  Jan 16, 2006
If your acne doesn’t respond, you may want to see your care provider for a stronger prescription lotion, such as tretinoin (Retin-A, Renova) or adapalene ... - Fort Wayne Journal Gazette,

Anti-Aging Skincare: Load on Vitamins!  Jan 16, 2006
...retinoids today in the reversal and prevention of photoaging was due to the research of a dermatologist who discovered that topical tretinoin improved wrinkling ... - Fashion Monitor Toronto,

Study This  Jan 7, 2006
...develop into ulcers. Might Retin-A (tretinoin), a topical skin rejuvenator, effectively treat these ulcers? • This study: randomly ... - Bryan College Station Eagle,

Other short-acting sympathomimetic aerosol bronchodilators should not be used concomitantly with albuterol. If additional adrenergic drugs are to be administered by any route, they should be used with caution to avoid deleterious cardiovascular effects.

Monoamine Oxidase Inhibitors or Tricyclic Antidepressants: Albuterol should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents, because the action of albuterol on the vascular system may be potentiated.

Beta-Blockers: Beta-adrenergic receptor blocking agents not only block the pulmonary effect of beta-agonists, such as VENTOLIN Inhalation Aerosol, but may produce severe bronchospasm in patients with asthma. Therefore, patients with asthma should not normally be treated with beta-blockers. However, under certain circumstances, e.g., as prophylaxis after myocardial infarction, there may be no acceptable alternatives to the use of beta-adrenergic blocking agents in patients with asthma. In this setting, cardioselective beta-blockers could be considered, although they should be administered with caution.

Diuretics: The ECG changes and/or hypokalemia that may result from the administration of nonpotassium-sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded. Although the clinical significance of these effects is not known, caution is advised in the coadministration of beta-agonists with nonpotassium-sparing diuretics.

Digoxin: Mean decreases of 16% to 22% in serum digoxin levels were demonstrated after single-dose intravenous and oral administration of albuterol, respectively, to normal volunteers who had received digoxin for 10 days. The clinical significance of these findings for patients with obstructive airway disease who are receiving albuterol and digoxin on a chronic basis is unclear. Nevertheless, it would be prudent to carefully evaluate the serum digoxin levels in patients who are currently receiving digoxin and albuterol.